Concepedia
Statistics
Publications
69
Citations
3.9K
H-Index
32
Active since
1974
Affiliations
Japan Society of Chemotherapy(Current)
The University of Osaka
Japanese Foundation For Cancer Research
Aomori Prefectural Central Hospital
National Cancer Center
T Taguchi is an author at Japan Society of Chemotherapy specializing in medicine, oncology, and chemotherapy.
Publications per year
1974–2014
Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patients
Yuh Sakata, Atsushi Ohtsu, N Horikoshi et al. · European Journal of Cancer · 1998 · 564 citations
Medicine, Oncology, Pharmacology +11
Phase II study of S-1, a novel oral fluoropyrimidine derivative, in patients with metastatic colorectal carcinoma
Atsushi Ohtsu, Hideo Baba, Yuh Sakata et al. · British Journal of Cancer · 2000 · 205 citations · Full text
Medicine, Oncology, Pharmacology +17
Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
Taroh Satoh, Isamu Okamoto, Masaki Miyazaki et al. · Clinical Cancer Research · 2009 · 176 citations
[Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group].
K Futatsuki, A Wakui, I Nakao et al. · PubMed · 1994 · 173 citations
Medicine, Oncology, Pharmacology +12
An Early Phase II Study of Oral S-1, a Newly Developed 5-Fluorouracil Derivative for Advanced and Recurrent Gastrointestinal Cancers
Keizō Sugimachi, Yoshihiko Maehara, N Horikoshi et al. · Oncology · 1999 · 171 citations
Medicine, Oncology, Pharmacology +16
1–5 of 69